CD4+ T cells sensitized by vascular smooth muscle induce vasculitis, and interferon gamma is critical for the initiation of vascular pathology

American Journal of Pathology

Volumn 177, Issue 6, 2010, Pages 3215-3223

  Baiu, Dana Carina ^a   Sandor, Matyas ^a   Hart, Michael ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNOPATHOGENESIS; LYMPHOCYTE PROLIFERATION; LYMPHOCYTIC INFILTRATION; MEMORY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PULMONARY VASCULITIS; SENSITIZATION; SMOOTH MUSCLE FIBER; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH17 CELL; TH2 CELL; VASCULAR SMOOTH MUSCLE; VASCULITIS;

EID: 78650191397     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.090985     Document Type: Article

References (44)

1. Watts RA, Scott DG: Epidemiology of the vasculitides. Curr Opin Rheumatol 2003, 15:11-16
2. Ma-Krupa W, Jeon MS, Spoerl S, Tedder TF, Goronzy JJ, Weyand CM: Activation of arterial wall dendritic cells and breakdown of self-tolerance in giant cell arteritis. J Exp Med 2004, 199:173-183 (Pubitemid 38129698)
3. Han JW, Shimada K, Ma-Krupa W, Johnson TL, Nerem RM, Goronzy JJ, Weyand CM: Vessel wall-embedded dendritic cells induce T-cell autoreactivity and initiate vascular inflammation. Circ Res 2008, 102:546-553
4. Swanson BJ, Baiu DC, Sandor M, Fabry Z, Hart MN: A small population of vasculitogenic T cells expands and has skewed T cell receptor usage after culture with syngeneic smooth muscle cells. J Autoimmun 2003, 20:125-133
5. Weyand CM, Schonberger J, Oppitz U, Hunder NN, Hicok KC, Goronzy JJ: Distinct vascular lesions in giant cell arteritis share identical T cell clonotypes. J Exp Med 1994, 179:951-960
6. Seko Y, Takahashi N, Tada Y, Yagita H, Okumura K, Nagai R: Restricted usage of T-cell receptor Vgamma-Vdelta genes and expression of costimulatory molecules in Takayasu's arteritis. Int J Cardiol 2000, 75 Suppl 1:S77-S83; discussion S85-S77
7. Jayne D: Evidence-based treatment of systemic vasculitis. Rheumatology (Oxford) 2000, 39:585-595
8. Schmitt WH, Hagen EC, Neumann I, Nowack R, Flores-Suarez LF, van der Woude FJ: Treatment of refractory Wegener's granulomatosis with antithymocyte globulin (ATG): an open study in 15 patients. Kidney Int 2004, 65:1440-1448
9. Brouwer E, Tervaert JW, Horst G, Huitema MG, van der Giessen M, Limburg PC, Kallenberg CG: Predominance of IgG1 and IgG4 subclasses of anti-neutrophil cytoplasmic autoantibodies (ANCA) in patients with Wegener's granulomatosis and clinically related disorders. Clin Exp Immunol 1991, 83:379-386
10. Tripathy NK, Chauhan SK, Nityanand S: Cytokine mRNA repertoire of peripheral blood mononuclear cells in Takayasu's arteritis. Clin Exp Immunol 2004, 138:369-374
11. Wagner AD, Bjornsson J, Bartley GB, Goronzy JJ, Weyand CM: Interferon-gamma-producing T cells in giant cell vasculitis represent a minority of tissue-infiltrating cells and are located distant from the site of pathology. Am J Pathol 1996, 148:1925-1933
12. Sohn MH, Noh SY, Chang W, Shin KM, Kim DS: Circulating interleukin 17 is increased in the acute stage of Kawasaki disease. Scand J Rheumatol 2003, 32:364-366
13. Saito H, Tsurikisawa N, Tsuburai T, Oshikata C, Akiyama K: Cytokine production profile of CD4+ T cells from patients with active Churg-Strauss syndrome tends toward Th17. Int Arch Allergy Immunol 2009, 149 Suppl 1:61-65
14. Abdulahad WH, Stegeman CA, van der Geld YM, Doornbos-van der Meer B, Limburg PC, Kallenberg CG: Functional defect of circulating regulatory CD4+ T cells in patients with Wegener's granulomatosis in remission. Arthritis Rheum 2007, 56:2080-2091
15. Hruskova Z, Rihova Z, Mareckova H, Jancova E, Rysava R, Zavada J, Merta M, Loster T, Tesar V: Intracellular cytokine production in ANCA-associated vasculitis: low levels of interleukin-10 in remission are associated with a higher relapse rate in the long-term follow-up. Arch Med Res 2009, 40:276-284
16. Wilde B, Dolff S, Cai X, Specker C, Becker J, Totsch M, Costabel U, Durig J, Kribben A, Tervaert JW, Schmid KW, Witzke O: CD4+CD25+ T-cell populations expressing CD134 and GITR are associated with disease activity in patients with Wegener's granulomatosis. Nephrol Dial Transplant 2009, 24:161-171
17. Valzasina B, Guiducci C, Dislich H, Killeen N, Weinberg AD, Colombo MP: Triggering of OX40 (CD134) on CD4(+)CD25+ T cells blocks their inhibitory activity: a novel regulatory role for OX40 and its comparison with GITR. Blood 2005, 105:2845-2851
18. Hart MN, Tassell SK, Sadewasser KL, Schelper RL, Moore SA: Autoimmune vasculitis resulting from in vitro immunization of lymphocytes to smooth muscle. Am J Pathol 1985, 119:448-455
19. Baiu DC, Barger B, Sandor M, Fabry Z, Hart MN: Autoantibodies to vascular smooth muscle are pathogenic for vasculitis. Am J Pathol 2005, 166:1851-1860 (Pubitemid 40734407)
20. Moore SA, Strauch AR, Yoder EJ, Rubenstein PA, Hart MN: Cerebral microvascular smooth muscle in tissue culture. In Vitro 1984, 20:512-520
21. Sanchez-Fueyo A, Tian J, Picarella D, Domenig C, Zheng XX, Sabatos CA, Manlongat N, Bender O, Kamradt T, Kuchroo VK, Gutierrez-Ramos JC, Coyle AJ, Strom TB: Tim-3 inhibits T helper type 1-mediated autoand alloimmune responses and promotes immunological tolerance. Nat Immunol 2003, 4:1093-1101
22. Pfister H, Ollert M, Frohlich LF, Quintanilla-Martinez L, Colby TV, Specks U, Jenne DE: Antineutrophil cytoplasmic autoantibodies against the murine homolog of proteinase 3 (Wegener autoantigen) are pathogenic in vivo. Blood 2004, 104:1411-1418
23. Xiao H, Heeringa P, Liu Z, Huugen D, Hu P, Maeda N, Falk RJ, Jennette JC: The role of neutrophils in the induction of glomerulonephritis by anti-myeloperoxidase antibodies. Am J Pathol 2005, 167:39-45
24. Katz P: Vasculitis. Edited by KF Austen, MM Frank, JP Atkinson, and H Cantor. Philadelphia, Lippincott Williams & Wilkins, 2001, pp 560-571
25. Abdulahad WH, Stegeman CA, Kallenberg CG: Review article: the role of CD4(+) T cells in ANCA-associated systemic vasculitis. Nephrology (Carlton) 2009, 14:26-32
26. Ruth AJ, Kitching AR, Kwan RY, Odobasic D, Ooi JD, Timoshanko JR, Hickey MJ, Holdsworth SR: Anti-neutrophil cytoplasmic antibodies and effector CD4+ cells play nonredundant roles in anti-myeloperoxidase crescentic glomerulonephritis. J Am Soc Nephrol 2006, 17:1940-1949
27. Hewins P, Tervaert JW, Savage CO, Kallenberg CG: Is Wegener's granulomatosis an autoimmune disease? Curr Opin Rheumatol 2000, 12:3-10
28. Bansal PJ, Tobin MC: Neonatal microscopic polyangiitis secondary to transfer of maternal myeloperoxidase-antineutrophil cytoplasmic antibody resulting in neonatal pulmonary hemorrhage and renal involvement. Ann Allergy Asthma Immunol 2004, 93:398-401
29. Schlieben DJ, Korbet SM, Kimura RE, Schwartz MM, Lewis EJ: Pulmonary-renal syndrome in a newborn with placental transmission of ANCAs. Am J Kidney Dis 2005, 45:758-761
30. Bajema IM, Bruijn JA: What stuff is this! A historical perspective on fibrinoid necrosis. J Pathol 2000, 191:235-238
31. Specks U: Are animal models of vasculitis suitable tools? Curr Opin Rheumatol 2000, 12:11-19
32. Dal Canto AJ, Virgin HW 4th: Animal models of infection-mediated vasculitis. Curr Opin Rheumatol. 1999, 11:17-23
33. Kamachi M, Le TM, Kim SJ, Geiger ME, Anderson P, Utz PJ: Human autoimmune sera as molecular probes for the identification of an autoantigen kinase signaling pathway. J Exp Med 2002, 196:1213-1225
34. Jacob CO, van der Meide PH, McDevitt HO: In vivo treatment of (NZB X NZW)F1 lupus-like nephritis with monoclonal antibody to gamma interferon. J Exp Med 1987, 166:798-803
35. Hartung HP, Schafer B, van der Meide PH, Fierz W, Heininger K, Toyka KV: The role of interferon-gamma in the pathogenesis of experimental autoimmune disease of the peripheral nervous system. Ann Neurol 1990, 27:247-257
36. Debray-Sachs M, Carnaud C, Boitard C, Cohen H, Gresser I, Bedossa P, Bach JF: Prevention of diabetes in NOD mice treated with antibody to murine IFN gamma. J Autoimmun 1991, 4:237-248
37. Willenborg DO, Fordham S, Bernard CC, Cowden WB, Ramshaw IA: IFN-gamma plays a critical down-regulatory role in the induction and effector phase of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. J Immunol 1996, 157:3223-3227
38. Vermeire K, Heremans H, Vandeputte M, Huang S, Billiau A, Matthys P: Accelerated collagen-induced arthritis in IFN-gamma receptor-deficient mice. J Immunol 1997, 158:5507-5513 (Pubitemid 127681260)
39. Manoury-Schwartz B, Chiocchia G, Bessis N, Abehsira-Amar O, Batteux F, Muller S, Huang S, Boissier MC, Fournier C: High susceptibility to collagen-induced arthritis in mice lacking IFN-gamma receptors. J Immunol 1997, 158:5501-5506
40. Matthys P, Vermeire K, Mitera T, Heremans H, Huang S, Schols D, De Wolf-Peeters C, Billiau A: Enhanced autoimmune arthritis in IFN-gamma receptor-deficient mice is conditioned by mycobacteria in Freund's adjuvant and by increased expansion of Mac-1+ myeloid cells. J Immunol 1999, 163:3503-3510
41. Hirota K, Hashimoto M, Yoshitomi H, Tanaka S, Nomura T, Yamaguchi T, Iwakura Y, Sakaguchi N, Sakaguchi S: T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis. J Exp Med 2007, 204:41-47
42. Eid RE, Rao DA, Zhou J, Lo SF, Ranjbaran H, Gallo A, Sokol SI, Pfau S, Pober JS, Tellides G: Interleukin-17 and interferon-gamma are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells. Circulation 2009, 119:1424-1432
43. Hartupee J, Liu C, Novotny M, Li X, Hamilton T: IL-17 enhances chemokine gene expression through mRNA stabilization. J Immunol 2007, 179:4135-4141
44. Laan M, Cui ZH, Hoshino H, Lotvall J, Sjostrand M, Gruenert DC, Skoogh BE, Linden A: Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J Immunol 1999, 162:2347-2352